307 related articles for article (PubMed ID: 28119111)
1. Cellular interactions of a lipid-based nanocarrier model with human keratinocytes: Unravelling transport mechanisms.
Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Acta Biomater; 2017 Apr; 53():439-449. PubMed ID: 28119111
[TBL] [Abstract][Full Text] [Related]
2. Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer.
Chai GH; Hu FQ; Sun J; Du YZ; You J; Yuan H
Mol Pharm; 2014 Oct; 11(10):3716-26. PubMed ID: 25197948
[TBL] [Abstract][Full Text] [Related]
3. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology.
Chai GH; Xu Y; Chen SQ; Cheng B; Hu FQ; You J; Du YZ; Yuan H
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5929-40. PubMed ID: 26860241
[TBL] [Abstract][Full Text] [Related]
4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
5. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum.
Guo T; Zhang Y; Zhao J; Zhu C; Feng N
J Nanobiotechnology; 2015 Jul; 13():47. PubMed ID: 26156035
[TBL] [Abstract][Full Text] [Related]
11. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells.
He B; Lin P; Jia Z; Du W; Qu W; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2013 Aug; 34(25):6082-98. PubMed ID: 23694903
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
Beloqui A; Solinís MÁ; Rodríguez-Gascón A; Almeida AJ; Préat V
Nanomedicine; 2016 Jan; 12(1):143-61. PubMed ID: 26410277
[TBL] [Abstract][Full Text] [Related]
13. Cellular interactions and photoprotective effects of idebenone-loaded nanostructured lipid carriers stabilized using PEG-free surfactant.
Kyadarkunte AY; Patole MS; Pokharkar VB
Int J Pharm; 2015 Feb; 479(1):77-87. PubMed ID: 25545795
[TBL] [Abstract][Full Text] [Related]
14. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery.
Hung CF; Chen WY; Hsu CY; Aljuffali IA; Shih HC; Fang JY
Eur J Pharm Biopharm; 2015 Aug; 94():94-105. PubMed ID: 25986584
[TBL] [Abstract][Full Text] [Related]
16. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
Zhang T; Chen J; Zhang Y; Shen Q; Pan W
Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654
[TBL] [Abstract][Full Text] [Related]
17. Mussel-Inspired Polydopamine Coating Enhances the Intracutaneous Drug Delivery from Nanostructured Lipid Carriers Dependently on a Follicular Pathway.
Chen Y; Feng X; Zhao Y; Zhao X; Zhang X
Mol Pharm; 2020 Apr; 17(4):1215-1225. PubMed ID: 32167771
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
Fan X; Chen J; Shen Q
Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy.
Daré RG; Costa A; Nakamura CV; Truiti MCT; Ximenes VF; Lautenschlager SOS; Sarmento B
Int J Pharm; 2020 May; 582():119336. PubMed ID: 32304728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]